XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Liabilities
 9 Months Ended
Sep. 30, 2014
Accrued Liabilities  
Accrued Liabilities

 

7.  Accrued Liabilities

 

Accrued liabilities are comprised of the following (and are included within the accounts payable and accrued expenses line item on the consolidated balance sheets), in thousands:

                                                                                                                                                                                                             

 

 

September 30,

 

December 31,

 

 

 

2014

 

2013

 

 

 

(unaudited)

 

 

 

 

 

 

 

 

 

Accrued clinical trial and clinical supply costs

 

$
877 

 

$
2,253 

 

Accrued compensation

 
5,011 

 
5,016 

 

Accrued sales rebates and allowances

 
7,298 

 
1,903 

 

Accrued product costs

 
1,909 

 
2,503 

 

Accrued sales and marketing expenses

 
807 

 
1,077 

 

Accrued interest

 
1,292 

 
619 

 

Other accrued liabilities

 
3,216 

 
1,801 

 

 

 

$
20,410 

 

$
15,172 

 

 

Accrued clinical trial and clinical supply costs consist primarily of investigator fees, contract research organization services, contract manufacturing, pass-through costs and laboratory costs.  Other accrued liabilities consist primarily of professional fees, distribution fees, and miscellaneous accrued expenses.